Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

Direct-to-consumer drug programs hold the promise of cheaper GLP-1s and other drugs, but buying drugs outside insurance benefits may be more costly— and risky — in the long run. More Americans are ...

New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...

In this conversation, Alison Pritchard, Ph.D., explains how ADHD and sleep problems can form a cycle in children and shares findings from ‘What Matters to Caregivers of Youth Wi ...

The CEO and founder of a digital behavior company has advice for health plans considering asynchronous behavioral health ...

A risk score built from 31 small RNA molecules found in blood was linked to lung cancer up to 10 years before diagnosis in a ...

The survey showed also showed differences in medical debt by race and ethnicity. Medical debt was more prevalent among Black adults (37.5%) and Hispanic adults (34.8%) than it was among White adults ...

Biosimilars can cost $600 a month versus $6,000 for branded rivals, but PBM rebate incentives push formularies toward pricier ...

In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.

The newest wave of cancer therapies, including CAR-T cell therapy, bispecific antibodies and antibody-drug conjugates, is ...

Lean MASLD/MASH comprises a meaningful subset of patients, with lean MASH linked to higher all-cause mortality and liver events despite lower cardiometabolic comorbidity than obese disease. Adding ...

A post-2018 16.8% rise in Hispanic HIV incidence in anti-sanctuary counties temporally aligned with public charge expansion to Medicaid, consistent with deterrence from prevention, testing, and ...